MedTrace Logo

Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn

NCT04024150 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2026-03-09

No results posted yet for this study

Summary

The objective of the study is to evaluate at birth, the diversity of the T repertoire of newborns exposed in utero to anti-integrases in comparison with a control group of children exposed to other antiretroviral drugs.

Conditions

  • Anti-integrases

Interventions

BIOLOGICAL

Blood test

Single blood sample of 2 ml at birth on the occasion of blood sampling routine checkup

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Stéphane Blanche, MD-PhD · Assistance Publique - Hôpitaux de Paris

  • Jean-Pierre de Villartay · Institut National de la Santé Et de la Recherche Médicale, France

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-04
Primary Completion
2021-01-14
Completion
2021-01-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04024150 on ClinicalTrials.gov